quinidine has been researched along with mexiletine in 123 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 75 (60.98) | 18.7374 |
1990's | 25 (20.33) | 18.2507 |
2000's | 11 (8.94) | 29.6817 |
2010's | 10 (8.13) | 24.3611 |
2020's | 2 (1.63) | 2.80 |
Authors | Studies |
---|---|
Bódi, I; Frank, L; Hankovszky, OH; Hideg, K | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
Bruno, C; Budriesi, R; Carbonara, R; Carocci, A; Catalano, A; Colabufo, NA; Conte Camerino, D; De Palma, A; Desaphy, JF; Di Mola, A; Franchini, C; Ghelardini, C; Lentini, G; Perrone, MG | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Julian, DG | 1 |
Theisen, K | 1 |
Koch-Weser, J | 1 |
Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA | 1 |
Kidner, PH | 1 |
Chin, M; Franz, M; Herre, JM; Katzung, B; Newman, D; Scheinman, MM | 1 |
Furukawa, T; Hiraoka, M; Marumo, F; Nitta, J; Sawanobori, T; Sunami, A | 1 |
Kanno, M; Nakaya, H; Oyama, Y; Shishido, Y | 1 |
Baĭer, T; Brakhmann, I; Khilbel, T; Kiubler, V; Shmitt, K; Valdeker, B | 1 |
Deiwick, M; Konertz, W; Scheld, HH; Weyand, M | 1 |
Fomina, IG; Iankin, VV | 1 |
Duff, HJ; Gillis, AM; Mitchell, LB; Sheldon, RS; Wyse, DG | 1 |
Duff, HJ; Rahmberg, M; Sheldon, RS | 1 |
Abdalla, A; Mazur, NA; Nazarenko, VA | 1 |
Arnold, RJ; Beck, JR; Beshansky, JR; Frishman, WH; Kaniecki, DJ; Kowey, PR; Podrid, PJ | 1 |
Kadish, A; Morady, F; Toivonen, L | 1 |
Gottlieb, SS; Weinberg, M | 1 |
Kadish, AH; Morady, F; Rosenheck, S; Schmaltz, S; Summitt, J | 1 |
Abdulla, AM; Frank, MJ; Manwaring, RL; Prisant, LM; Russell, SL; Smith, MS; Watkins, LO | 1 |
Ford, SE; Saunders, SL | 1 |
Broly, F; Caron, J; Lhermitte, M; Libersa, C; Vandamme, N | 1 |
Kuang, Y; Liu, TP | 1 |
Giardina, EG; Wechsler, ME | 1 |
Accettura, D; De Toma, L; Lagioia, R; Mangini, SG; Mastropasqua, F; Rizzon, P; Scrutinio, D | 1 |
Podrid, PJ | 2 |
Honerjäger, P; Loibl, E; Schönsteiner, G; Steidl, I; Ulm, K | 1 |
Bajaj, AK; Cassidy, F; Kopelman, HA; Roden, DM; Wikswo, JP; Woosley, RL | 1 |
Accettura, D; Caiati, C; De Toma, L; Lagioia, R; Mangini, SG; Mastropasqua, F; Rizzon, P; Scrutinio, D | 1 |
Iansmith, DH; Roden, DM; Woosley, RL | 1 |
Abdalla, A; Mazur, NA | 2 |
Graboys, TB; Grossbard, CL; Lown, B; Patt, MV | 1 |
Abdalla, A; Iavorskaia, NV; Mazur, NA; Sumarokov, AB | 1 |
Sanchez-Chapula, J; Valenzuela, C | 1 |
Costard-Jaeckle, A; Franz, MR; Liem, LB | 1 |
Barbey, JT; Echt, DS; Kopelman, HA; Murray, KT; Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Cannon, NJ; Duff, HJ; Sheldon, RS | 1 |
Assey, ME; Hanger, KH; Hudson, WM; Miller, SC | 1 |
Duff, HJ | 1 |
Costard-Jäckle, A; Franz, MR | 1 |
Yamaguchi, I | 1 |
Somberg, J | 1 |
Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Roy, D | 1 |
Anderson, JL | 1 |
Belhassen, B; Laniado, S; Pines, A | 1 |
Morganroth, J; Nestico, PF | 2 |
Huang, SK; Marcus, FI | 1 |
Lampert, S; Lown, B; Podrid, PJ; Slater, W | 1 |
Cody, DV; Denniss, AR; Richards, DA; Ross, DL; Russell, PA; Uther, JB; Young, AA | 2 |
Duff, HJ; Manyari, DE; Mitchell, LB; Sheldon, RS; Wyse, DG | 1 |
Morganroth, J | 1 |
Garan, H; McElroy, M; McGovern, B; Newell, JB; Ruskin, JN; Schoenfeld, MH; Whitford, EG | 1 |
Celentano, A; de Divitiis, O; Fazio, S; Iacono, C; Petitto, M; Santomauro, M; Villari, B | 1 |
Horowitz, LN; Kay, HR; Kutalek, SP; Rae, AP; Spielman, SR | 1 |
Duff, HJ; Manyari, D; Mitchell, LB; Wyse, DG | 1 |
Cook, TS; DiMarco, JP; Nygaard, TW; Sellers, TD | 1 |
Bardy, GH; Fahrenbruch, CE; Graham, EL; Greene, HL; Poole, JE; Pulaski, WP; Werner, JA | 1 |
Giles, TD; Thomas, MG | 1 |
Hirosawa, K; Kasanuki, H; Onishi, S | 1 |
Collignon, P; Legrand, V | 1 |
Berman, ND; Burke, GH; Loukides, JE | 1 |
Greenspan, AM; Horowitz, LN; Rae, AP; Sokoloff, NM; Spielman, SR; Webb, CR | 2 |
Adinolfi, L; Bonaduce, D; Chiariello, M; Dote, I; Golia, B; Masullo, LA | 1 |
Opie, LH | 1 |
Schmitz, W | 1 |
Burckhardt, D; Follath, F; Hoffmann, A | 1 |
Hillis, WS; Whiting, B | 1 |
Somberg, JC | 1 |
Ceci, V; Di Marcotullio, G; Dini, P; Milazzotto, F; Polizzi, C; Santini, M | 1 |
Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D | 1 |
Jahrmärker, H; Theisen, K | 1 |
Kurbanov, RD; Mazur, NA | 1 |
Courtney, KR | 1 |
Cerskus, I; Duff, HJ; Roden, D; Siddoway, L; Stone, W; Thompson, K; Wang, T; Woosley, RL | 1 |
Fenster, PE; Hanson, CD | 1 |
Adams, E; Flessas, A; Kocot, SL; Rasul, AM; Shah, A; Singh, JB | 1 |
Rosen, MR; Wit, AL | 1 |
Block, PJ; Winkle, RA | 1 |
Bigger, JT | 1 |
Burckhardt, D; Follath, F; Hoffmann, A; Schütz, E; White, R | 1 |
Chiang, BN; Hong, CY | 1 |
Flouvat, B | 1 |
Duff, HJ; Oates, JA; Primm, RK; Roden, D; Woosley, RL | 1 |
DiMarco, JP; Garan, H; Ruskin, JN | 1 |
Ban, T; Oshita, S; Sada, H | 1 |
Adgey, AA; Logan, KR; McIlwaine, WJ; Pantridge, JF | 1 |
Bigger, JT; Giardina, EG; Leahey, EB; Reiffel, JA | 1 |
Bova, S; Magnolfi, G; Padrini, R; Piovan, D; Yang, Q | 1 |
Broly, F; Courseau, C; Lhermitte, M; Libersa, C; Vandamme, N | 1 |
Biblo, LA; Carlson, MD; Waldo, AL | 1 |
Bonavita, GJ; Cuello, C; Greene, TO; Huang, SK; Mittleman, RS; Pires, LA; Wagshal, AB | 1 |
Abolfathi, Z; Bélanger, PM; Fiset, C; Gilbert, M; Moerike, K; Turgeon, J | 1 |
Campbell, TJ; Wyse, KR; Ye, V | 1 |
Fernández del Pozo, B; Fernández, C; Pérez-Vizcaíno, F; Tamargo, J; Zaragozá, F | 1 |
Ishii, K; Kubota, Y; Moriuchi, H; Nakahara, T; Sakamato, K; Shigenobu, K; Tanaka, Y; Yunoki, M | 1 |
Ackerman, MJ; Jahangir, A; Makielski, JC; Munger, TM; Porter, CB; Rok, BA; Tester, DJ; Valdivia, CR | 1 |
Ai, T; Cheng, J; Li, Z; Merkle, EM; Razavi, M; Shuraih, M; Sohma, Y; Taylor, E; Towbin, JA; Vatta, M; Xi, Y | 1 |
Chen, YW; Cheng, KI; Chu, CC; Chu, KS; Huang, KL; Tzeng, JI; Wang, JJ | 1 |
Chen, YC; Chen, YW; Chu, CC; Leung, YM; Wang, JJ | 1 |
Cros, C; Lainee, P; Moors, J; Skinner, M; Valentin, JP | 1 |
Osadchii, OE | 1 |
Jæger, KH; Tveito, A; Wall, S | 1 |
Deschênes, I; Zheng, Y | 1 |
20 review(s) available for quinidine and mexiletine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cardiac arrhythmias - a short review.
Topics: Adrenergic beta-Agonists; Arrhythmias, Cardiac; Digitalis Glycosides; Electric Countershock; Electrocardiography; Humans; Lidocaine; Mexiletine; Pacemaker, Artificial; Phenytoin; Procainamide; Quinidine; Verapamil | 1976 |
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
Topics: Animals; Arrhythmias, Cardiac; Drug Therapy, Combination; Electrophysiology; Heart; Humans; Mexiletine; Quinidine; Sodium Channels | 1991 |
Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine.
Topics: Ambulatory Care; Arrhythmias, Cardiac; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Making, Computer-Assisted; Decision Support Techniques; Decision Trees; Hospitalization; Humans; Meta-Analysis as Topic; Mexiletine; Myocardial Infarction; Probability; Procainamide; Quinidine; Sensitivity and Specificity; Time Factors | 1991 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide | 1985 |
[The interaction of antiarrhythmic drugs with other drugs].
Topics: Adrenergic beta-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Digoxin; Drug Interactions; Humans; Lidocaine; Mexiletine; Phenytoin; Procainamide; Quinidine | 1985 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Rationale of combination antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Digitalis Glycosides; Drug Therapy, Combination; Humans; Mexiletine; Myocardial Infarction; Quinidine; Tachycardia; Verapamil | 1985 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Quinidine; Sodium; Tocainide | 1980 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide | 1984 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardiac Complexes, Premature; Digoxin; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1980 |
Pharmacology, electrophysiology, and pharmacokinetics of mexiletine.
Topics: Absorption; Animals; Arrhythmias, Cardiac; Drug Combinations; Drug Evaluation; Electrophysiology; Humans; Ion Channels; Kinetics; Mexiletine; Propylamines; Purkinje Fibers; Quinidine | 1984 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
22 trial(s) available for quinidine and mexiletine
Article | Year |
---|---|
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
[Prospective course of therapy arresting attacks of atrial fibrillation in patients with preexcitation syndromes].
Topics: Adult; Aged; Aged, 80 and over; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Pre-Excitation Syndromes; Procainamide; Propranolol; Quinidine; Time Factors; Verapamil | 1992 |
[Comparative effectiveness of class I anti-arrhythmia drugs and the algorithms of their selection in patients with ventricular arrhythmia].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Heart Conduction System; Heart Ventricles; Humans; Mexiletine; Middle Aged; Quinidine | 1991 |
Comparative hemodynamic effects of mexiletine and quinidine in patients with severe left ventricular dysfunction.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Drug Evaluation; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Mexiletine; Middle Aged; Quinidine; Time Factors | 1991 |
Mexiletine versus quinidine as first-line antiarrhythmia therapy: results from consecutive trials.
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Mexiletine; Middle Aged; Quinidine; Retrospective Studies; Tachycardia | 1991 |
Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Humans; Male; Mexiletine; Quinidine; Randomized Controlled Trials as Topic; Single-Blind Method; Stroke Volume | 1990 |
[Comparison of mexiletine and dihydroquinidine in the treatment of ventricular asystolic arrhythmia].
Topics: Adult; Aged; Arrhythmias, Cardiac; Asthenia; Cardiac Complexes, Premature; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Male; Mexiletine; Middle Aged; Propylamines; Quinidine; Random Allocation | 1985 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide | 1985 |
[Experience in using anti-arrhythmia preparations of groups I and III in patients with arrhythmia resistant to therapy].
Topics: Aconitine; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Phenothiazines; Quinidine | 1988 |
[Comparative study of the effectiveness of allapinin in patients with frequent and stable extrasystole].
Topics: Aconitine; Aconitum; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Phenothiazines; Placebos; Propranolol; Quinidine | 1988 |
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Electric Stimulation; Female; Heart Ventricles; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Prospective Studies; Quinidine; Random Allocation; Tocainide | 1989 |
Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Double-Blind Method; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Propylamines; Quinidine; Random Allocation | 1985 |
Randomized controlled trial of prophylactic antiarrhythmic therapy in patients with inducible ventricular tachyarrhythmias after recent myocardial infarction.
Topics: Actuarial Analysis; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electric Stimulation; Electrocardiography; Heart Ventricles; Humans; Mexiletine; Myocardial Infarction; Prognosis; Quinidine; Random Allocation | 1988 |
Effect of oral combination therapy with mexiletine and quinidine on left and right ventricular function.
Topics: Cardiac Pacing, Artificial; Clinical Trials as Topic; Drug Therapy, Combination; Electrophysiology; Exercise Test; Female; Humans; Male; Mexiletine; Middle Aged; Myocardial Contraction; Quinidine; Stroke Volume; Tachycardia | 1988 |
Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias.
Topics: Administration, Oral; Arrhythmias, Cardiac; Central Nervous System Diseases; Clinical Trials as Topic; Electrocardiography; Female; Gastrointestinal Diseases; Humans; Male; Mexiletine; Quinidine | 1987 |
[Antiarrhythmic efficacy and tolerance of slow-release mexiletine in comparison with hydroquinidine retard].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Delayed-Action Preparations; Drug Evaluation; Exercise Test; Female; Humans; Male; Mexiletine; Middle Aged; Quinidine; Random Allocation | 1987 |
Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Tachycardia; Time Factors; Ventricular Fibrillation | 1987 |
[Comparative effectiveness of ethmozine, mexitil, quinidine and obsidan in the treatment of ventricular rhythm disorders].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Humans; Mexiletine; Middle Aged; Moricizine; Morpholines; Phenothiazines; Placebos; Propranolol; Quinidine | 1981 |
Mexiletine and quinidine in ventricular ectopy.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Propylamines; Quinidine | 1983 |
Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Propylamines; Quinidine | 1984 |
Insights into the Electrophysiology Study Versus Electrocardiographic Monitoring Trial: its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Bias; Cardiac Pacing, Artificial; Drug Combinations; Electrocardiography, Ambulatory; Electrophysiology; Follow-Up Studies; Humans; Mexiletine; Procainamide; Quinidine; Research Design; Retrospective Studies; Sotalol; Tachycardia, Ventricular | 1995 |
Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electric Stimulation; Electrocardiography; Female; Humans; Male; Mexiletine; Middle Aged; Prospective Studies; Quinidine; Tachycardia, Ventricular; Treatment Failure | 1994 |
83 other study(ies) available for quinidine and mexiletine
Article | Year |
---|---|
New antiarrhythmic agents. 2,2,5,5-Tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethylpyrrolidine-3-carboxamindes.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation, Preclinical; Indicators and Reagents; Magnetic Resonance Spectroscopy; Nicotine; Ouabain; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship | 1986 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Ataxia; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Caco-2 Cells; Guinea Pigs; Heart; Heart Rate; HEK293 Cells; Humans; Ion Channel Gating; Mexiletine; Mice; NAV1.5 Voltage-Gated Sodium Channel; Permeability; Sodium Channels; Stereoisomerism; Vasodilator Agents | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1978 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1978 |
Prevention of ventricular arrhythmias after myocardial infarction.
Topics: Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Procainamide; Propranolol; Quinidine; Ventricular Fibrillation | 1977 |
Effects of sympathetic stimulation on use dependence of lidocaine, mexiletine, and quinidine in an intact canine model.
Topics: Action Potentials; Animals; Chromatography, High Pressure Liquid; Dogs; Electric Stimulation; Female; Heart Conduction System; In Vitro Techniques; Lidocaine; Male; Mexiletine; Quinidine; Sodium Channels; Stellate Ganglion; Sympathetic Nervous System | 1992 |
Combined class I antiarrhythmic agents have differential effects on tonic and use dependent block of maximum rate of depolarisation of action potentials in guinea pig cardiac muscle.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Aprindine; Disopyramide; Drug Combinations; Guinea Pigs; Lidocaine; Mexiletine; Myocardium; Quinidine; Sodium Channels | 1992 |
Voltage-dependent modification of Vmax recovery from use-dependent block by pirmenol in guinea pig papillary muscles: comparison with other class I drugs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disopyramide; Flecainide; Guinea Pigs; Heart; In Vitro Techniques; Membrane Potentials; Mexiletine; Microelectrodes; Neuromuscular Depolarizing Agents; Papillary Muscles; Piperidines; Propylamines; Pyridines; Quinidine; Sodium Channels | 1992 |
[Anti-arrhythmia agents in heart failure].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Flecainide; Humans; Mexiletine; Middle Aged; Propafenone; Quinidine | 1992 |
Is pretransplant antiarrhythmic drug therapy a risk factor?
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Cause of Death; Child; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Mexiletine; Middle Aged; Postoperative Complications; Premedication; Propafenone; Quinidine; Sotalol; Survival Rate; Transplantation, Heterotopic | 1992 |
Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Diazepam; Dogs; Drug Combinations; Drug Interactions; Heart Conduction System; Mexiletine; Quinidine; Quinine; Refractory Period, Electrophysiological | 1990 |
A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Encainide; Heart Conduction System; Humans; Mexiletine; Prospective Studies; Quinidine; Tachycardia | 1991 |
The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.
Topics: Adaptation, Physiological; Adult; Aged; Drug Evaluation; Electrophysiology; Female; Heart; Heart Rate; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine; Syncope; Tachycardia; Tachycardia, Paroxysmal | 1991 |
Primary coronary artery dissection possibly related to drug hypersensitivity in a male.
Topics: Aortic Dissection; Coronary Aneurysm; Drug Hypersensitivity; Humans; Male; Mexiletine; Middle Aged; Quinidine | 1991 |
Single-dose quinidine treatment inhibits mexiletine oxidation in extensive metabolizers of debrisoquine.
Topics: Debrisoquin; Drug Antagonism; Humans; Metabolic Clearance Rate; Mexiletine; Oxidation-Reduction; Quinidine | 1991 |
Rate-dependent depression of maximal rate of depolarization in guinea pig papillary muscle action potentials by changrolin.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Female; Guinea Pigs; In Vitro Techniques; Male; Mexiletine; Papillary Muscles; Piperidines; Quinazolines; Quinidine | 1990 |
Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade.
Topics: Action Potentials; Androstanols; Animals; Anti-Arrhythmia Agents; Aprindine; Calcium; Depression, Chemical; Disopyramide; Dose-Response Relationship, Drug; Female; Guinea Pigs; Ion Channels; Isoquinolines; Kinetics; Male; Membrane Potentials; Mexiletine; Microelectrodes; Myocardial Contraction; Myocardium; Potassium; Quinidine; Sodium; Sodium-Potassium-Exchanging ATPase; Sparteine; Tetrodotoxin | 1986 |
Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart.
Topics: Animals; Cardiac Pacing, Artificial; Dogs; Drug Combinations; Electrocardiography; Heart Conduction System; Ion Channels; Mexiletine; Myocardial Contraction; Quinidine; Sodium | 1987 |
[Evaluation of delayed-action preparations of mexiletine and dihydroquinidine in the treatment of ventricular extrasystolic arrhythmia].
Topics: Aged; Cardiac Complexes, Premature; Delayed-Action Preparations; Double-Blind Method; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine; Random Allocation | 1987 |
Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
Topics: Action Potentials; Animals; Dogs; Drug Synergism; Electric Stimulation; Heart Conduction System; In Vitro Techniques; Ion Channels; Mexiletine; Purkinje Fibers; Quinidine; Sodium | 1987 |
[The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
Topics: Aconitine; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Electrocardiography; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Phenothiazines; Quinidine | 1988 |
Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Monitoring, Physiologic; Quinidine; Tachycardia; Tocainide | 1988 |
Electrophysiologic interactions between mexiletine-quinidine and mexiletine-ropitoin in guinea pig papillary muscle.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Drug Interactions; Electric Stimulation; Electrophysiology; Female; Guinea Pigs; Heart; In Vitro Techniques; Kinetics; Male; Membrane Potentials; Mexiletine; Papillary Muscles; Phenytoin; Quinidine; Temperature | 1989 |
Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
Topics: Action Potentials; Animals; Blood Pressure; Dogs; Drug Therapy, Combination; Female; Heart Rate; In Vitro Techniques; Male; Mexiletine; Neural Conduction; Quinidine; Refractory Period, Electrophysiological | 1989 |
Mexiletine-quinidine in isolated hearts: an interaction involving the sodium channel.
Topics: Action Potentials; Animals; Coronary Disease; Drug Synergism; Drug Therapy, Combination; Heart; Heart Ventricles; Mexiletine; Myocardial Infarction; Myocardial Reperfusion; Quinidine; Rabbits; Sodium Channels; Tetrodotoxin; Ventricular Fibrillation | 1989 |
Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Drug Synergism; Drug Therapy, Combination; Heart Conduction System; Mexiletine; Quinidine | 1989 |
Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dogs; Female; Heart; Heart Conduction System; Heart Ventricles; Lidocaine; Male; Mexiletine; Quinidine | 1989 |
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combination; Electrophysiology; Fluocortolone; Humans; Male; Mexiletine; Quinidine; Sarcoidosis; Tachycardia | 1989 |
Clinical predictors of arrhythmia worsening by antiarrhythmic drugs.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Encainide; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine; Retrospective Studies | 1988 |
Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Tachycardia; Time Factors | 1988 |
Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans.
Topics: Adult; Aged; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine; Tachycardia | 1987 |
Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Prospective Studies; Quinidine; Tachycardia; Ventricular Fibrillation | 1986 |
Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Topics: Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Female; Humans; Male; Mexiletine; Middle Aged; Monitoring, Physiologic; Nausea; Procainamide; Propylamines; Quinidine; Recurrence; Tachycardia; Tremor; Ventricular Fibrillation | 1986 |
Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
Topics: Action Potentials; Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Heart Ventricles; Humans; Metoprolol; Mexiletine; Middle Aged; Myocardial Infarction; Quinidine; Tachycardia | 1986 |
Mexiletine: long-term follow-up of a patient with prolonged QT interval and quinidine-induced torsades de pointes.
Topics: Electrocardiography; Follow-Up Studies; Humans; Long-Term Care; Male; Mexiletine; Middle Aged; Propylamines; Quinidine; Tachycardia | 1985 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatography, High Pressure Liquid; Disopyramide; Electric Stimulation; Electrocardiography; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Infarction; Propafenone; Propiophenones; Quinidine; Tachycardia, Paroxysmal; Time Factors; Tocainide; Verapamil | 1985 |
Aggravation of ventricular arrhythmia. A drug-induced complication.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
Haemodynamic effects of class I antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Disopyramide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1985 |
Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
Topics: Action Potentials; Animals; Dogs; Dose-Response Relationship, Drug; Electric Conductivity; Heart; In Vitro Techniques; Lidocaine; Membrane Potentials; Mexiletine; Propylamines; Purkinje Fibers; Quinidine; Sodium; Time Factors | 1986 |
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electric Stimulation; Electrophysiology; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Time Factors | 1985 |
Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Disease; Drug Therapy, Combination; Electrophysiology; Female; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Tachycardia; Ventricular Fibrillation | 1985 |
[Ventricular tachycardia].
Topics: Amiodarone; Aprindine; Digitalis Glycosides; Electrocardiography; Heart Aneurysm; Heart Ventricles; Humans; Mexiletine; Pacemaker, Artificial; Propranolol; Quinidine; Risk; Tachycardia; Tachycardia, Paroxysmal | 1985 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Heart Conduction System; Hemodynamics; Humans; Lidocaine; Mexiletine; Procainamide; Quinidine; Verapamil | 1980 |
Safe treatment of resistant ventricular arrhythmias with a combination of amiodarone and quinidine or mexiletine.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Therapy, Combination; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine | 1983 |
Antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide; Verapamil | 1983 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
[Combinations of some anti-arrhythmia drugs].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Humans; Mexiletine; Propafenone; Propiophenones; Quinidine | 1984 |
Depressant effects of drugs used in myotonia therapy.
Topics: Animals; In Vitro Techniques; Ion Channels; Lidocaine; Mexiletine; Muscle Contraction; Myotonia; Phenytoin; Procainamide; Quinidine; Rana catesbeiana; Tocainide | 1982 |
The interaction of mexiletine with other cardiovascular drugs.
Topics: Absorption; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Drug Therapy, Combination; Humans; Kinetics; Mexiletine; Propylamines; Quinidine | 1984 |
Suppression of high-grade ventricular ectopic activity by antiarrhythmic drug treatment as a marker for survival in patients with chronic coronary artery disease.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Female; Humans; Male; Mexiletine; Middle Aged; Phenytoin; Prognosis; Quinidine; Retrospective Studies | 1984 |
Local anaesthetic effect of antiarrhythmic drugs and human sperm immobilization: mechanism and application of the interrelationship.
Topics: Anesthetics, Local; Anti-Arrhythmia Agents; Diltiazem; Humans; Labetalol; Male; Mexiletine; Procainamide; Quinidine; Sperm Immobilizing Agents | 1984 |
[Determination of plasma concentrations of anti-arrhythmia agents].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biological Availability; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine | 1981 |
Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
Topics: Arrhythmias, Cardiac; Coronary Disease; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Heart Ventricles; Humans; Mexiletine; Patient Compliance; Propylamines; Quinidine; Tachycardia; Ventricular Fibrillation | 1983 |
Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
Topics: Aged; Drug Therapy, Combination; Electric Stimulation; Electrocardiography; Female; Humans; Male; Mexiletine; Middle Aged; Propranolol; Quinidine; Tachycardia; Ventricular Fibrillation | 1983 |
Effects of mexiletine on transmembrane action potentials as affected by external potassium concentration and by rate of stimulation in guinea-pig papillary muscles.
Topics: Action Potentials; Animals; Electric Stimulation; Female; Guinea Pigs; Heart; In Vitro Techniques; Male; Mexiletine; Papillary Muscles; Potassium; Propylamines; Quinidine | 1980 |
Recurrence of ventricular fibrillation in acute ischemic heart disease.
Topics: Acute Disease; Anti-Arrhythmia Agents; Coronary Disease; Female; Heart Arrest; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Infarction; Quinidine; Recurrence; Resuscitation; Ventricular Fibrillation | 1981 |
The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study.
Topics: Aged; Anorexia; Anti-Arrhythmia Agents; Digoxin; Disopyramide; Drug Interactions; Female; Humans; Male; Mexiletine; Middle Aged; Nausea; Procainamide; Prospective Studies; Quinidine; Vomiting | 1980 |
Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Guanidines; Guinea Pigs; Heart; Male; Mexiletine; Pinacidil; Potassium Channels; Quinidine; Vasodilator Agents | 1995 |
Stereoselective hydroxylation of mexiletine in human liver microsomes: implication of P450IID6--a preliminary report.
Topics: Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Dextromethorphan; Humans; Hydroxylation; In Vitro Techniques; Mexiletine; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Polymorphism, Genetic; Quinidine; Stereoisomerism | 1993 |
Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans.
Topics: Administration, Oral; Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Humans; Male; Mexiletine; Mixed Function Oxygenases; Phenotype; Polymorphism, Genetic; Quinidine; Stereoisomerism | 1993 |
Effects of hyperkalaemia on the depression of maximum rate of depolarization by class I antiarrhythmic agents in guinea-pig myocardium.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disopyramide; Female; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Male; Mexiletine; Microelectrodes; Potassium; Quinidine | 1993 |
Effects of several class I antiarrhythmic drugs on isolated rat aortic vascular smooth muscle.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Desipramine; Disopyramide; Flecainide; Imipramine; In Vitro Techniques; Lidocaine; Male; Mexiletine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Quinidine; Rats; Rats, Sprague-Dawley | 1997 |
Involvement of K(+) channel in procainamide-induced relaxation of bovine tracheal smooth muscle.
Topics: Albuterol; Animals; Anti-Arrhythmia Agents; Bronchoconstrictor Agents; Bronchodilator Agents; Cattle; In Vitro Techniques; Methacholine Chloride; Mexiletine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Potassium; Potassium Channels; Procainamide; Propafenone; Quinidine; Trachea | 2000 |
A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Topics: Adolescent; Animals; Arrhythmias, Cardiac; Cell Line; Humans; Long QT Syndrome; Male; Mexiletine; Mutation, Missense; Myocardium; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Pedigree; Quinidine; Sodium Channel Blockers; Sodium Channels; Transfection | 2004 |
A common SCN5A variant alters the responsiveness of human sodium channels to class I antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Cells, Cultured; Flecainide; Genetic Variation; Humans; Ion Channel Gating; Mexiletine; Muscle Proteins; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Quinidine; Sodium Channels | 2007 |
The cutaneous analgesic effect of class I antiarrhythmic drugs.
Topics: Analgesics; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Bupivacaine; Dose-Response Relationship, Drug; Flecainide; Injections, Subcutaneous; Lidocaine; Male; Mexiletine; Pain Measurement; Pain Threshold; Quinidine; Rats; Rats, Sprague-Dawley; Reflex; Skin; Sodium Channel Blockers; Time Factors | 2007 |
Spinal blockades of class I antiarrythmic drugs with bupivacaine by isobolographic analysis in rats.
Topics: Anesthesia, Spinal; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Bupivacaine; Dose-Response Relationship, Drug; Flecainide; Injections, Spinal; Male; Mexiletine; Quinidine; Rats; Rats, Sprague-Dawley | 2012 |
Detecting drug-induced prolongation of the QRS complex: new insights for cardiac safety assessment.
Topics: Animals; CHO Cells; Cricetinae; Dogs; Electrocardiography; Flecainide; Heart Rate; Male; Mexiletine; Patch-Clamp Techniques; Quinidine; Telemetry; Voltage-Gated Sodium Channel Blockers | 2012 |
Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiological Phenomena; Female; Flecainide; Guinea Pigs; Heart Ventricles; Lidocaine; Mexiletine; Quinidine; Sodium Channel Blockers; Tachycardia, Ventricular | 2014 |
Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes.
Topics: Action Potentials; Adult; Ajmaline; Algorithms; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Computational Biology; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Heart Conduction System; Heart Defects, Congenital; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ivabradine; Mexiletine; Models, Cardiovascular; Mutation; Myocytes, Cardiac; Quinidine; Translational Research, Biomedical | 2021 |
Protein 14-3-3 Influences the Response of the Cardiac Sodium Channel Na
Topics: 14-3-3 Proteins; Anti-Arrhythmia Agents; HEK293 Cells; Humans; Lidocaine; Mexiletine; Quinidine; Sodium Channels | 2023 |